Clinton E. Leysath

1.3k total citations
20 papers, 1.0k citations indexed

About

Clinton E. Leysath is a scholar working on Molecular Biology, Ecology and Genetics. According to data from OpenAlex, Clinton E. Leysath has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Ecology and 6 papers in Genetics. Recurrent topics in Clinton E. Leysath's work include Bacillus and Francisella bacterial research (11 papers), Bacteriophages and microbial interactions (6 papers) and Bacterial Genetics and Biotechnology (6 papers). Clinton E. Leysath is often cited by papers focused on Bacillus and Francisella bacterial research (11 papers), Bacteriophages and microbial interactions (6 papers) and Bacterial Genetics and Biotechnology (6 papers). Clinton E. Leysath collaborates with scholars based in United States, South Korea and New Zealand. Clinton E. Leysath's co-authors include Stephen H. Leppla, Marina Konopleva, Michael Andreeff, Zonglin Hu, David N. Garboczi, Kavita Singh, Zeev Estrov, Charles B. Shoemaker, Jacqueline M. Tremblay and Rasem Fattah and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Clinton E. Leysath

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clinton E. Leysath United States 16 621 227 200 144 124 20 1.0k
Erhard Kopetzki Germany 21 574 0.9× 98 0.4× 239 1.2× 120 0.8× 88 0.7× 29 1.1k
Adolfo Soffientini Italy 18 551 0.9× 241 1.1× 231 1.2× 196 1.4× 75 0.6× 30 1.1k
Gerd Zettlmeißl Germany 20 823 1.3× 183 0.8× 217 1.1× 51 0.4× 127 1.0× 33 1.3k
Kristen Jensen-Pergakes United States 13 665 1.1× 67 0.3× 390 1.9× 199 1.4× 115 0.9× 15 964
Kazuhito Ohishi Japan 20 979 1.6× 419 1.8× 77 0.4× 212 1.5× 42 0.3× 30 1.7k
Andrew Chen United States 13 788 1.3× 133 0.6× 45 0.2× 155 1.1× 70 0.6× 29 1.1k
Steven L. Giardina United States 14 367 0.6× 372 1.6× 37 0.2× 181 1.3× 207 1.7× 16 810
Halina Miller‐Podraza Sweden 22 991 1.6× 341 1.5× 134 0.7× 50 0.3× 83 0.7× 46 1.4k
Gholamreza Hassanzadeh‐Ghassabeh Belgium 18 668 1.1× 273 1.2× 51 0.3× 157 1.1× 621 5.0× 25 1.1k
Dion Kaiserman Australia 21 498 0.8× 558 2.5× 185 0.9× 167 1.2× 26 0.2× 36 1.2k

Countries citing papers authored by Clinton E. Leysath

Since Specialization
Citations

This map shows the geographic impact of Clinton E. Leysath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinton E. Leysath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinton E. Leysath more than expected).

Fields of papers citing papers by Clinton E. Leysath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clinton E. Leysath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clinton E. Leysath. The network helps show where Clinton E. Leysath may publish in the future.

Co-authorship network of co-authors of Clinton E. Leysath

This figure shows the co-authorship network connecting the top 25 collaborators of Clinton E. Leysath. A scholar is included among the top collaborators of Clinton E. Leysath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clinton E. Leysath. Clinton E. Leysath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyer, Anne E., Zsuzsanna Kuklenyik, Adrian R. Woolfitt, et al.. (2019). Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax. Analytical and Bioanalytical Chemistry. 411(12). 2493–2509. 10 indexed citations
2.
Chen, Kuang‐Hua, Shihui Liu, Clinton E. Leysath, et al.. (2016). Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting. Journal of Biological Chemistry. 291(42). 22021–22029. 17 indexed citations
3.
Moayeri, Mahtab, Clinton E. Leysath, Jacqueline M. Tremblay, et al.. (2015). A Heterodimer of a VHH (Variable Domains of Camelid Heavy Chain-only) Antibody That Inhibits Anthrax Toxin Cell Binding Linked to a VHH Antibody That Blocks Oligomer Formation Is Highly Protective in an Anthrax Spore Challenge Model. Journal of Biological Chemistry. 290(10). 6584–6595. 32 indexed citations
4.
Bachran, Christopher, P. K. Gupta, Clinton E. Leysath, et al.. (2014). Reductive Methylation and Mutation of an Anthrax Toxin Fusion Protein Modulates its Stability and Cytotoxicity. Scientific Reports. 4(1). 4754–4754. 11 indexed citations
5.
Bachran, Christopher, Clinton E. Leysath, Inka Sastalla, et al.. (2014). Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins. Cell Death and Disease. 5(1). e1003–e1003. 24 indexed citations
6.
Fattah, Rasem, Devorah Crown, Yi Zhang, et al.. (2013). Engineering Anthrax Toxin Variants That Exclusively Form Octamers and Their Application to Targeting Tumors. Journal of Biological Chemistry. 288(13). 9058–9065. 32 indexed citations
7.
Leysath, Clinton E., et al.. (2013). Anthrax Edema Factor Toxicity Is Strongly Mediated by the N-end Rule. PLoS ONE. 8(8). e74474–e74474. 11 indexed citations
8.
Moayeri, Mahtab, Devorah Crown, Guan‐Sheng Jiao, et al.. (2013). Small-Molecule Inhibitors of Lethal Factor Protease Activity Protect against Anthrax Infection. Antimicrobial Agents and Chemotherapy. 57(9). 4139–4145. 17 indexed citations
9.
Tremblay, Jacqueline M., Jean Mukherjee, Clinton E. Leysath, et al.. (2013). A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2. Infection and Immunity. 81(12). 4592–4603. 76 indexed citations
10.
Garboczi, David N., et al.. (2013). The sub‐nanomolar binding of DNA–RNA hybrids by the single‐chain Fv fragment of antibody S9.6. Journal of Molecular Recognition. 26(8). 376–381. 122 indexed citations
11.
Mukherjee, Jean, Jacqueline M. Tremblay, Clinton E. Leysath, et al.. (2012). A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model. PLoS ONE. 7(1). e29941–e29941. 73 indexed citations
12.
Leysath, Clinton E., Kuang‐Hua Chen, Mahtab Moayeri, et al.. (2011). Mouse Monoclonal Antibodies to Anthrax Edema Factor Protect against Infection. Infection and Immunity. 79(11). 4609–4616. 21 indexed citations
13.
Radjainia, Mazdak, Jaekyung Hyun, Clinton E. Leysath, Stephen H. Leppla, & Alok K. Mitra. (2010). Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex. Proceedings of the National Academy of Sciences. 107(32). 14070–14074. 14 indexed citations
14.
Seo, Min Jeong, Ki Jun Jeong, Clinton E. Leysath, et al.. (2009). Engineering antibody fragments to fold in the absence of disulfide bonds. Protein Science. 18(2). 259–267. 24 indexed citations
15.
Leysath, Clinton E., A.F. Monzingo, Jennifer A. Maynard, et al.. (2009). Crystal Structure of the Engineered Neutralizing Antibody M18 Complexed to Domain 4 of the Anthrax Protective Antigen. Journal of Molecular Biology. 387(3). 680–693. 29 indexed citations
16.
Jin, Linhua, Yoko Tabe, Sergej Konoplev, et al.. (2008). CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Molecular Cancer Therapeutics. 7(1). 48–58. 151 indexed citations
17.
Monaco, Giuseppe, Marina Konopleva, Mark F. Munsell, et al.. (2004). Engraftment of Acute Myeloid Leukemia in NOD/SCID Mice Is Independent of CXCR4 and Predicts Poor Patient Survival. Stem Cells. 22(2). 188–201. 38 indexed citations
18.
Konopleva, Marina, Twee Tsao, Peter P. Ruvolo, et al.. (2002). Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood. 99(1). 326–335. 157 indexed citations
19.
Milella, Michèle, Zeev Estrov, Steven M. Kornblau, et al.. (2002). Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia. Blood. 99(9). 3461–3464. 100 indexed citations
20.
Morton, Phillip A., James A. Stewart, K S Giacoletto, et al.. (1996). Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). The Journal of Immunology. 156(3). 1047–1054. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026